Dirk Hasenclever

10PUBLICATIONS
44CO-AUTHORS
Haematological tumoursAdolescent healthEnvironmental epidemiologyRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 16, 2026
Canakinumab or emavusertib for anemia in lower-risk MDS: results of the CANFIRE and LUCAS phase 2, open-label, multicenter trials.

|Jun 03, 2026
EuroNet-PHL-LP1: complete resection or low-dose chemotherapy for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.

|Oct 17, 2024
EFFECT of daily antiseptic bathing with octenidine on ICU-acquired bacteremia and ICU-acquired multidrug-resistant organisms: a multicenter, cluster-randomized, double-blind, placebo-controlled, cross-over study.

Tiffany Schaumburg, Norbert Köhler, Yasmine Breitenstein

|Sep 11, 2024
Semen analysis and reproductive hormones in boys with classical Hodgkin lymphoma treated according to the EuroNet-PHL-C2 protocol.

K C E Drechsel, S L Broer, H M K van Breda

|Aug 21, 2024
The effectiveness of telephone surveys on the return of first-time donors: A randomized controlled trial.

Vanessa C Marsano, Dirk Hasenclever, Reinhard Henschler

|May 25, 2024
The impact of treatment for childhood classical Hodgkin lymphoma according to the EuroNet-PHL-C2 protocol on serum anti-Müllerian Hormone.

K C E Drechsel, S L Broer, F S Stoutjesdijk

Pageof 2

Frequent Collaborators

3 joint publications

Auke Beishuizen

3 joint publications

Christine Mauz-Koerholz

3 joint publications

Michaela Cepelova

2 joint publications

K C E Drechsel